These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10083069)

  • 21. Human leukocyte antigen mismatches predispose to the severity of bronchiolitis obliterans syndrome after lung transplantation.
    Chalermskulrat W; Neuringer IP; Schmitz JL; Catellier DJ; Gurka MJ; Randell SH; Aris RM
    Chest; 2003 Jun; 123(6):1825-31. PubMed ID: 12796156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Indirect recognition of donor HLA class I peptides in lung transplant recipients with bronchiolitis obliterans syndrome.
    SivaSai KS; Smith MA; Poindexter NJ; Sundaresan SR; Trulock EP; Lynch JP; Cooper JD; Patterson GA; Mohanakumar T
    Transplantation; 1999 Apr; 67(8):1094-8. PubMed ID: 10232557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-HLA class I antibody binding to airway epithelial cells induces production of fibrogenic growth factors and apoptotic cell death: a possible mechanism for bronchiolitis obliterans syndrome.
    Jaramillo A; Smith CR; Maruyama T; Zhang L; Patterson GA; Mohanakumar T
    Hum Immunol; 2003 May; 64(5):521-9. PubMed ID: 12691702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of pre-transplant anti-HLA antibodies and their impact on outcomes in lung transplant recipients.
    Park JE; Kim CY; Park MS; Song JH; Kim YS; Lee JG; Paik HC; Kim SY
    BMC Pulm Med; 2018 Mar; 18(1):45. PubMed ID: 29529999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The histopathology of lung allograft dysfunction associated with the development of donor-specific HLA alloantibodies.
    Yousem SA; Zeevi A
    Am J Surg Pathol; 2012 Jul; 36(7):987-92. PubMed ID: 22510758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA mismatches influence lung transplant recipient survival, bronchiolitis obliterans and rejection: implications for donor lung allocation.
    Peltz M; Edwards LB; Jessen ME; Torres F; Meyer DM
    J Heart Lung Transplant; 2011 Apr; 30(4):426-34. PubMed ID: 21145259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Donor-specific antibodies are associated with antibody-mediated rejection, acute cellular rejection, bronchiolitis obliterans syndrome, and cystic fibrosis after lung transplantation.
    Lobo LJ; Aris RM; Schmitz J; Neuringer IP
    J Heart Lung Transplant; 2013 Jan; 32(1):70-7. PubMed ID: 23260706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Redo living-donor lobar lung transplantation for bronchiolitis obliterans associated with antibody-mediated rejection.
    Chen F; Miyagawa-Hayashino A; Yurugi K; Chibana N; Yamada T; Sato M; Aoyama A; Takakura S; Bando T; Date H
    Transpl Int; 2014 Feb; 27(2):e8-12. PubMed ID: 24164400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preferential production of IgG2 antibodies by parenchymal lung B-lymphocytes during lung allograft rejection.
    Wilkes DS; Sidner RA; Mathur PN; Niemeier M; Schwenk R; Heidler KM; Bowen LK
    Transplant Proc; 1997 May; 29(3):1891-5. PubMed ID: 9142313
    [No Abstract]   [Full Text] [Related]  

  • 30. [Graft dysfunction, acute rejection and bronchiolitis obliterans in lung and heart-lung transplantation].
    Sleiman C; Groussard O; Mal H; Fournier M
    Rev Mal Respir; 1996 Nov; 13(5 Suppl):S31-40. PubMed ID: 9011909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does bronchial artery revascularization influence results concerning bronchiolitis obliterans syndrome and/or obliterative bronchiolitis after lung transplantation?
    Nørgaard MA; Andersen CB; Pettersson G
    Eur J Cardiothorac Surg; 1998 Sep; 14(3):311-8. PubMed ID: 9761443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The number of FoxP3+ cells in transbronchial lung allograft biopsies does not predict bronchiolitis obliterans syndrome within the first five years after transplantation.
    Krustrup D; Iversen M; Martinussen T; Schultz HH; Andersen CB
    Clin Transplant; 2015 Mar; 29(3):179-84. PubMed ID: 25533723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. De Novo DQ Donor-Specific Antibodies Are Associated with Chronic Lung Allograft Dysfunction after Lung Transplantation.
    Tikkanen JM; Singer LG; Kim SJ; Li Y; Binnie M; Chaparro C; Chow CW; Martinu T; Azad S; Keshavjee S; Tinckam K
    Am J Respir Crit Care Med; 2016 Sep; 194(5):596-606. PubMed ID: 26967790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C4d deposition in lung allografts is associated with circulating anti-HLA alloantibody.
    Ionescu DN; Girnita AL; Zeevi A; Duquesnoy R; Pilewski J; Johnson B; Studer S; McCurry KR; Yousem SA
    Transpl Immunol; 2005 Oct; 15(1):63-8. PubMed ID: 16223674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Donor-specific HLA alloantibodies: long-term impact on cardiac allograft vasculopathy and mortality after heart transplant.
    Kaczmarek I; Deutsch MA; Kauke T; Beiras-Fernandez A; Schmoeckel M; Vicol C; Sodian R; Reichart B; Spannagl M; Ueberfuhr P
    Exp Clin Transplant; 2008 Sep; 6(3):229-35. PubMed ID: 18954302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The killer immunoglobulin-like receptor (KIR) group A haplotype is associated with bronchiolitis obliterans syndrome after lung transplantation.
    Kwakkel-van Erp JM; van de Graaf EA; Paantjens AW; van Ginkel WG; Schellekens J; van Kessel DA; van den Bosch JM; Otten HG
    J Heart Lung Transplant; 2008 Sep; 27(9):995-1001. PubMed ID: 18765192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tacrolimus for treatment of bronchiolitis obliterans syndrome after unilateral and bilateral lung transplantation.
    Fieguth HG; Krueger S; Wiedenmann DE; Otterbach I; Wagner TO
    Transplant Proc; 2002 Aug; 34(5):1884. PubMed ID: 12176613
    [No Abstract]   [Full Text] [Related]  

  • 38. Bronchoalveolar lavage cytokine profile in a cohort of lung transplant recipients: a predictive role of interleukin-12 with respect to onset of bronchiolitis obliterans syndrome.
    Meloni F; Vitulo P; Cascina A; Oggionni T; Bulgheroni A; Paschetto E; Klersy C; D'Armini AM; Fietta A; Bianco AM; Arbustini E; Viganò M
    J Heart Lung Transplant; 2004 Sep; 23(9):1053-60. PubMed ID: 15454171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of anti-HLA antibody production following renal transplantation in sensitised, immunoadsorbed patients.
    Bevan DJ; Carey BS; Vaughan RW; Fallon M; Higgins RM; Hendry BM; Bewick M
    Transplant Proc; 1997; 29(1-2):1448. PubMed ID: 9123375
    [No Abstract]   [Full Text] [Related]  

  • 40. Animal models for bronchiolitis obliterans syndrome following human lung transplantation.
    Kuo E; Bharat A; Dharmarajan S; Fernandez F; Patterson GA; Mohanakumar T
    Immunol Res; 2005; 33(1):69-81. PubMed ID: 16120973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.